NM_003742.4:c.167C>T

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM1BP6

The NM_003742.4(ABCB11):​c.167C>T​(p.Ser56Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000686 in 1,613,068 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/24 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S56P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00049 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00071 ( 1 hom. )

Consequence

ABCB11
NM_003742.4 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:3

Conservation

PhyloP100: 3.50

Publications

6 publications found
Variant links:
Genes affected
ABCB11 (HGNC:42): (ATP binding cassette subfamily B member 11) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is the major canalicular bile salt export pump in man. Mutations in this gene cause a form of progressive familial intrahepatic cholestases which are a group of inherited disorders with severe cholestatic liver disease from early infancy. [provided by RefSeq, Jul 2008]
ABCB11 Gene-Disease associations (from GenCC):
  • progressive familial intrahepatic cholestasis type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • benign recurrent intrahepatic cholestasis type 2
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_003742.4
BP6
Variant 2-169013494-G-A is Benign according to our data. Variant chr2-169013494-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 382469.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003742.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCB11
NM_003742.4
MANE Select
c.167C>Tp.Ser56Leu
missense
Exon 5 of 28NP_003733.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCB11
ENST00000650372.1
MANE Select
c.167C>Tp.Ser56Leu
missense
Exon 5 of 28ENSP00000497931.1O95342
ABCB11
ENST00000858973.1
c.209C>Tp.Ser70Leu
missense
Exon 5 of 28ENSP00000529032.1
ABCB11
ENST00000858972.1
c.167C>Tp.Ser56Leu
missense
Exon 5 of 27ENSP00000529031.1

Frequencies

GnomAD3 genomes
AF:
0.000493
AC:
75
AN:
152090
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000926
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000555
AC:
138
AN:
248608
AF XY:
0.000512
show subpopulations
Gnomad AFR exome
AF:
0.000194
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000466
Gnomad NFE exome
AF:
0.00112
Gnomad OTH exome
AF:
0.000498
GnomAD4 exome
AF:
0.000706
AC:
1031
AN:
1460860
Hom.:
1
Cov.:
31
AF XY:
0.000711
AC XY:
517
AN XY:
726642
show subpopulations
African (AFR)
AF:
0.0000898
AC:
3
AN:
33406
American (AMR)
AF:
0.000157
AC:
7
AN:
44614
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26114
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86220
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53380
Middle Eastern (MID)
AF:
0.000521
AC:
3
AN:
5760
European-Non Finnish (NFE)
AF:
0.000874
AC:
971
AN:
1111352
Other (OTH)
AF:
0.000613
AC:
37
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
48
96
144
192
240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000493
AC:
75
AN:
152208
Hom.:
0
Cov.:
32
AF XY:
0.000336
AC XY:
25
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41534
American (AMR)
AF:
0.0000654
AC:
1
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000926
AC:
63
AN:
68000
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000922
Hom.:
0
Bravo
AF:
0.000480
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000267
AC:
1
ESP6500EA
AF:
0.000487
AC:
4
ExAC
AF:
0.000646
AC:
78
EpiCase
AF:
0.000928
EpiControl
AF:
0.00113

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
1
Progressive familial intrahepatic cholestasis type 2 (3)
-
1
1
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
16
DANN
Benign
0.97
DEOGEN2
Benign
0.27
T
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.26
FATHMM_MKL
Benign
0.68
D
LIST_S2
Uncertain
0.89
D
M_CAP
Uncertain
0.094
D
MetaRNN
Benign
0.033
T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
1.8
L
PhyloP100
3.5
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.69
N
REVEL
Benign
0.17
Sift
Benign
0.44
T
Sift4G
Benign
0.59
T
Polyphen
0.031
B
Vest4
0.20
MVP
0.79
MPC
0.14
ClinPred
0.018
T
GERP RS
2.6
Varity_R
0.060
gMVP
0.30
Mutation Taster
=71/29
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.40
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.40
Position offset: 16

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11568361; hg19: chr2-169870004; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.